Grace Therapeutics/$GRCE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Grace Therapeutics
Grace Therapeutics Inc is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its development pipeline consists of the following product candidates: GTx-104, a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage (aSAH); GTx-102, targeted for the treatment of ataxia-telangiectasia (A-T) in a pediatric population; and GTx-101, a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia (PHN), which can be persistent and often causes debilitating pain following infection by the shingles virus. The company has one reportable operating segment: the development and commercialization of pharmaceutical applications of its patents and licensed rights.
Ticker
$GRCE
Sector
Primary listing
Employees
5
Headquarters
Website
GRCE Metrics
BasicAdvanced
$34m
-
-$0.47
0.37
-
Price and volume
Market cap
$34m
Beta
0.37
52-week high
$5.18
52-week low
$1.79
Average daily volume
272k
Financial strength
Current ratio
8.099
Quick ratio
7.92
Profitability
EBITDA (TTM)
-11.07
Effective tax rate (TTM)
17.91%
Management effectiveness
Return on assets (TTM)
-9.99%
Return on equity (TTM)
-11.94%
Valuation
Price to book
0.52
Price to tangible book (TTM)
2.27
Price to free cash flow (TTM)
-3.854
Free cash flow yield (TTM)
-25.95%
Free cash flow per share (TTM)
-0.537
Growth
Earnings per share change (TTM)
-40.37%
3-year earnings per share growth (CAGR)
-56.43%
GRCE News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.